ATE503847T1 - Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten - Google Patents

Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten

Info

Publication number
ATE503847T1
ATE503847T1 AT07849642T AT07849642T ATE503847T1 AT E503847 T1 ATE503847 T1 AT E503847T1 AT 07849642 T AT07849642 T AT 07849642T AT 07849642 T AT07849642 T AT 07849642T AT E503847 T1 ATE503847 T1 AT E503847T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
kits
methods
probably
diagnosing
Prior art date
Application number
AT07849642T
Other languages
English (en)
Inventor
Anat Achiron
Michael Gurevich
Original Assignee
Tel Hashomer Medical Res Infrastructure & Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel Hashomer Medical Res Infrastructure & Services Ltd filed Critical Tel Hashomer Medical Res Infrastructure & Services Ltd
Application granted granted Critical
Publication of ATE503847T1 publication Critical patent/ATE503847T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AT07849642T 2006-12-29 2007-12-27 Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten ATE503847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87768206P 2006-12-29 2006-12-29
PCT/IL2007/001616 WO2008081434A2 (en) 2006-12-29 2007-12-27 Methods and kits for diagnosis of multiple sclerosis in probable multiple sclerosis subjects

Publications (1)

Publication Number Publication Date
ATE503847T1 true ATE503847T1 (de) 2011-04-15

Family

ID=39365845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07849642T ATE503847T1 (de) 2006-12-29 2007-12-27 Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten

Country Status (6)

Country Link
US (1) US20100112568A1 (de)
EP (1) EP2121971B1 (de)
AT (1) ATE503847T1 (de)
CA (1) CA2673595A1 (de)
DE (1) DE602007013615D1 (de)
WO (1) WO2008081434A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522754B1 (de) * 2007-08-13 2014-04-02 Baxter International Inc. IVIg-Modulation von Chemokinen zur Behandlung von Multipler Sklerose, Morbus Alzheimer und Morbus Parkinson
US20110281750A1 (en) * 2008-07-24 2011-11-17 The Regents Of The University Of California, A California Corporation Identifying High Risk Clinically Isolated Syndrome Patients
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
GB201909619D0 (en) * 2019-07-04 2019-08-21 Univ Oxford Innovation Ltd Methods for diagnosing multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001087903A2 (en) * 2000-05-18 2001-11-22 Genaissance Pharmaceuticals, Inc. Haplotypes of the acaa1 gene
WO2003081201A2 (en) * 2002-03-21 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
AUPS271902A0 (en) * 2002-05-31 2002-06-20 Griffith University Gene expression and multiple sclerosis

Also Published As

Publication number Publication date
EP2121971B1 (de) 2011-03-30
DE602007013615D1 (de) 2011-05-12
CA2673595A1 (en) 2008-07-10
WO2008081434A2 (en) 2008-07-10
WO2008081434A3 (en) 2009-02-12
EP2121971A2 (de) 2009-11-25
US20100112568A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
EP1810026A4 (de) B7-h1 und verfahren zur diagnose, prognose und behandlung von krebs
GB201300533D0 (en) Methods of monitoring conditions by sequence analysis
IN2014CN01787A (de)
WO2010013454A1 (ja) 運転診断装置、および運転診断システム
JP2009538607A5 (de)
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
BRPI0607753A2 (pt) método para prever um efeito clìnico em resposta a um tratamento de uma leucemia; método para prever um efeito clìnico de uma leucemia; método para selecionar um tratamento para um paciente com leucemia; método para o diagnóstico ou monitoramento de ocorrência, desenvolvimento, progressão ou tratamento de uma leucemia; arranjo para uso num método para prever um efeito clìnico para um paciente aml; arranjo para uso num método de diagnóstico de aml; meio legìvel por computador; kit para o prognóstico de aml
EP2569635A4 (de) Verfahren zur diagnose und/oder behandlung von enzephalitis oder epilepsie
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
WO2008081435A3 (en) Methods and kits for predicting prognosis of multiple sclerosis
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
GB201021399D0 (en) Oligonucleotide probe set and methods of microbiota profiling
Sharma et al. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis
WO2017178621A3 (en) Methods and devices for measuring the levels of analytes in body fluids
WO2011021041A3 (en) Survival prognostic assay
Gupta et al. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the I ndian subcontinent
WO2011133770A3 (en) Salivary protein markers for detection of breast cancer
MX2017003370A (es) Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
ATE503847T1 (de) Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten
EA201290056A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2008080030A3 (en) Cardiovascular autoimmune disease panel and methods of using same
BR112015014232A2 (pt) lesão renal aguda
ATE456801T1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a- komplexe in einer blutprobe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties